摘要
目的:研究近4年来北京天坛医院神经内科多发性脑梗死患者用药状况,为临床合理、有效、经济用药提供依据。方法:采用医院住院系统对近4年来神经内科多发性脑梗死患者用药进行分析、统计。结果:心血管系统用药金额最大,抗感染药物、水、热量、电解质、酸碱平衡药以及神经系统药物用药金额次之。用药量最大的是复方丹参滴丸。DDDs排序第一的是舒尔利粉针(胞磷胆碱)。结论:我院神经内科多发性脑梗死患者用药合理性需进一步探讨。
Objective: To analyze the prescription in the patients with multiple cerebral infarctions for the recent 4 years and provide references for rational, efficient and economical use of this kind of drug in clinic. Methods: The cost, amount of medication used by the patients with multiple cerebral infarction were investigated and analyzed by in-patient system. Results: The drug with highest expense was cardiovascular drug. The followed drugs were anti-infective drugs, liquid, calorie, nervous system agents, acid-base balance electrolyte agents. Fufang Danshen drop pills was used with the largest amount in the pa.tients. The first place of DDDs was citicoline. Conclusion: Further research of rational medication should be accomplished for patients with multiple cerebral infarction in our hospital.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2008年第3期251-253,共3页
Chinese Journal of New Drugs
关键词
多发性脑梗死
用药分析
multiple cerebral infarction
analysis of medication